NDC 43538-300-99 - CENTANY
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43538-300
- Requested NDC
- 43538-300-99
- Package NDCs from labels
- 43538-300-30, 43538-300-99, 43538-300-24
- Manufacturer
- Medimetriks Pharmaceuticals Inc | Perrigo, Inc
- Effective date
- 2017-11-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CENTANY - Medimetriks Pharmaceuticals Inc | Perrigo, Inc | Medimetriks Pharmaceuticals Inc | Perrigo, Inc | 2017-11-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43538-300-30 | GM - Gram | 43538-300 | 3fe4c5b3-6dbd-4c94-a860-161e0fe4a2c6 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MUPIROCIN | ACTIVE INGREDIENT | D0GX863OA5 | CENTANY (MUPIROCIN) OINTMENT [MEDIMETRIKS PHARMACEUTICALS INC] | 2 | |
| MUPIROCIN | ACTIVE MOIETY | D0GX863OA5 | CENTANY (MUPIROCIN) OINTMENT [MEDIMETRIKS PHARMACEUTICALS INC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mupirocin | MUPIROCIN | Advanced Rx Pharmacy of Tennessee, LLC | f1a048d9-af57-a4a2-e053-2995a90a8663 | 2024-12-31 | Warnings, Adverse reactions | D0GX863OA5 |
| Mupirocin | MUPIROCIN | Advanced Rx Pharmacy of Tennessee, LLC | f1a01044-8f2e-4e91-e053-2995a90af722 | 2024-12-31 | Warnings, Adverse reactions | D0GX863OA5 |
| Mupirocin | MUPIROCIN | NuCare Pharmaceuticals,Inc. | 66db1071-024f-aa19-e053-2a91aa0a8e39 | 2024-06-06 | Warnings, Adverse reactions | D0GX863OA5 |
| mupirocin | MUPIROCIN | A-S Medication Solutions | a6c22c25-0f02-4c06-bbc2-723a18ecdda8 | 2024-01-30 | Warnings, Adverse reactions | D0GX863OA5 |
| mupirocin | MUPIROCIN | Padagis Israel Pharmaceuticals Ltd | e9b61f01-3c67-42a4-a62b-10f1d1343190 | 2023-12-31 | Warnings, Adverse reactions | D0GX863OA5 |
| Mupirocin | MUPIROCIN | Proficient Rx LP | 2777e4f2-2b8d-41f5-a96a-02dec8c7c3e0 | 2023-11-01 | Warnings, Adverse reactions | D0GX863OA5 |
| mupirocin | MUPIROCIN | Bryant Ranch Prepack | 1cd4c71f-138b-47c2-8ce8-9ac32408dc56 | 2023-07-18 | Warnings, Adverse reactions | D0GX863OA5 |
| Mupirocin | MUPIROCIN | Proficient Rx LP | d8766748-6b53-4673-a3ee-5cd8a4301647 | 2023-01-01 | Warnings, Adverse reactions | D0GX863OA5 |
| 6ccd171b-715c-4374-9465-1ebf79c3e6a6 | 90cfa2dc-3904-4bd3-b951-dcdb141883bf | 2022-11-03 | Warnings, Adverse reactions | 90cfa2dc-3904-4bd3-b951-dcdb141883bf | ||
| Mupirocin | MUPIROCIN | Proficient Rx LP | cbb18010-f3b5-4ed7-8c03-c9203f0e360e | 2022-10-01 | Warnings, Adverse reactions | D0GX863OA5 |
| Mupirocin | MUPIROCIN | Teva Pharmaceuticals USA, Inc. | a543797a-2c1c-4ea3-bd6c-227a784f92d9 | 2022-05-01 | Warnings, Adverse reactions | D0GX863OA5 |
| mupirocin | MUPIROCIN | Proficient Rx LP | 97f8d67d-c422-4a26-9394-24a5ec9719d9 | 2022-04-01 | Warnings, Adverse reactions | D0GX863OA5 |
| mupirocin | MUPIROCIN | Asclemed USA, Inc. | b2ff9c56-ca19-48ca-bd08-4b33edb13a08 | 2020-11-09 | Warnings, Adverse reactions | D0GX863OA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.